HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-01-16Clinical Trial Update: RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART) [Phase 1]
A Phase 1 trial of RHIV for HIV infections refractory or intolerant to HAART has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-11-25Clinical Trial Update: Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating treatment for paradoxical TB-IRIS has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-11-13Clinical Trial Update: Immune Response to Hepatitis C Virus
A clinical trial evaluating the immune response to hepatitis C virus sponsored by Emory University has been withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2013-07-15Clinical Trial Update: SCOPE: Strategies to Combine PrEP With Prevention Efforts [NA]
The SCOPE trial assessing strategies to combine pre-exposure prophylaxis with HIV prevention efforts has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-30Clinical Trial Update: Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women
The study examining how the menstrual cycle influences antiretroviral pharmacokinetics in HIV-infected women has been withdrawn from clinica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-03-29Clinical Trial Update: A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects [Phase 2]
Phase 2 safety and efficacy study of amdoxovir in HIV-1 treatment-experienced subjects was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-22Clinical Trial Update: Garlic in Hyperlipidemia Caused by HAART [Phase 2]
This update indicates a Phase 2 trial evaluating garlic for HAART-induced hyperlipidemia in people with HIV has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-19Clinical Trial Update: Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART [NA]
This clinical trial evaluated a mixed exercise regime combined with L-Carnitine supplementation in HIV patients on HAART. The study has been…
-
CLINICAL_TRIALS withdrawal · 2012-12-05Clinical Trial Update: An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons [NA]
This open-label trial studied whether valacyclovir affects plasma HIV-1 levels in HIV-1 seropositive, HSV-1/2 seronegative adults. The study…
-
CLINICAL_TRIALS withdrawal · 2012-11-08Clinical Trial Update: A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir [Phase 3]
A multicenter Phase 3 trial evaluating second-line antiretroviral regimens with atazanavir or lopinavir/ritonavir in African adults has been…
-
CLINICAL_TRIALS withdrawal · 2012-10-29Clinical Trial Update: Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV [NA]
A clinical trial investigating anti-HIV medications with structured treatment interruptions in people recently infected with HIV has been wi…
-
CLINICAL_TRIALS withdrawal · 2012-08-16Clinical Trial Update: Botswana Study of UC-781 Vaginal Microbicide [Phase 1]
A Phase 1 Botswana trial evaluating the UC-781 vaginal microbicide for HIV prevention has been withdrawn. The sponsor is the Centers for Dis…
-
CLINICAL_TRIALS withdrawal · 2012-06-11Clinical Trial Update: A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa [Phase 3]
Phase 3 trial evaluating the dapivirine vaginal ring for HIV prevention in Africa has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-06-11Clinical Trial Update: A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa [Phase 3]
A Phase 3 trial evaluating the dapivirine vaginal ring for HIV prevention in Africa has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: HLA-B35 Alleles and AIDS
A clinical trial investigating HLA-B35 alleles and AIDS has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-04-27Clinical Trial Update: A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects [Phase 2]
A Phase 2 multiple ascending dose study of BMS-707035 in HIV-1 infected subjects has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-03-29Clinical Trial Update: Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum
A clinical trial evaluating the pharmacokinetics of raltegravir during the third trimester of pregnancy and postpartum has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-03-28Clinical Trial Update: Pharmacotherapy for HIV Infected Patients With Alcohol Problems [Phase 4]
Phase 4 clinical trial update on pharmacotherapy for HIV-infected patients with alcohol problems; the study status has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-02-29Clinical Trial Update: Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy [Phase 1]
The HIV study NCT00757250 evaluating TXA127 to raise CD4+ T-cell counts in patients on HAART has been terminated.
-
CLINICAL_TRIALS withdrawal · 2012-02-15Clinical Trial Update: Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial [Phase 3]
A Phase 3 trial evaluating EFV-TDF-FTC and AZT-3TC-LPV/r regimens for preventing mother-to-child transmission of HIV in pregnant and breastf…
-
CLINICAL_TRIALS withdrawal · 2012-02-09Clinical Trial Update: Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers. [Phase 1]
A Phase 1 trial evaluating safety and pharmacokinetics of escalating oral doses of BI-224436 in healthy male volunteers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-01-20Clinical Trial Update: Predictors of Drug Hypersensitivity in HIV Infected Subjects
A clinical trial titled Predictors of Drug Hypersensitivity in HIV Infected Subjects has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-01-19Clinical Trial Update: Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients [Phase 4]
A Phase 4 trial comparing maraviroc versus etravirine in combination antiretroviral therapy for drug-experienced HIV patients co-infected wi…
-
CLINICAL_TRIALS withdrawal · 2011-09-09Clinical Trial Update: A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium [Phase 1]
A Phase 1 safety and pharmacokinetic study of a dapivirine and maraviroc gel for HIV infections in Belgium has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-08-09Clinical Trial Update: Epoetin Alfa for HIV-Associated Neuropathy Trial [Phase 2]
The Phase 2 trial of epoetin alfa for HIV-associated neuropathy has been withdrawn.